Search results for "Review"

showing 10 items of 4492 documents

IL-33/IL-31 Axis: A Potential Inflammatory Pathway

2018

Cytokines play an important role in the regulation of the immune system (adaptive and innate). Given their importance in proinflammatory processes, cytokines have been used for understanding the pathogenesis and as biomarkers in many diseases. IL-31 and IL-33 are still considered novel cytokines. IL-31 controls signalling and regulates a huge amount of biological functions: it induces proinflammatory cytokines, regulates cell proliferation, and is involved also in tissue remodelling. On the other hand, IL-33 has been identified as an “alarmin” released from the epithelial cells and from different human tissues and organs after a damage following, that is, an inflammatory process. The aim of…

0301 basic medicineIL-33/IL-31 AxiImmunologyInflammationReview ArticleAdaptive ImmunityBiologyProinflammatory cytokinePathogenesis03 medical and health sciences0302 clinical medicineImmune systemSettore MED/43 - Medicina Legalelcsh:PathologymedicineAnimalsHumansIL-33/IL-31 Axis; Inflammatory PathwayInflammationAdaptive Immunity; Animals; Biomarkers; Humans; Inflammation; Interleukin-33; Interleukins; Immunology; Cell BiologyCell growthInterleukinsInterleukinCell BiologyInterleukin-33Acquired immune systemInflammatory PathwayInterleukin 33030104 developmental biologyImmunologymedicine.symptomBiomarkerslcsh:RB1-214030215 immunology
researchProduct

Extravascular coagulation in hematopoietic stem and progenitor cell regulation

2018

Abstract The hemostatic system plays pivotal roles in injury repair, innate immunity, and adaptation to inflammatory challenges. We review the evidence that these vascular-protective mechanisms have nontraditional roles in hematopoietic stem cell (HSC) maintenance in their physiological bone marrow (BM) niches at steady-state and under stress. Expression of coagulation factors and the extrinsic coagulation initiator tissue factor by osteoblasts, tissue-resident macrophages, and megakaryocytes suggests that endosteal and vascular HSC niches are functionally regulated by extravascular coagulation. The anticoagulant endothelial protein C receptor (EPCR; Procr) is highly expressed by primitive …

0301 basic medicineImmunologyBone Marrow Cells030204 cardiovascular system & hematologyBiologyThrombomodulinBiochemistry03 medical and health sciences0302 clinical medicineBone MarrowStress PhysiologicalmedicineAnimalsHumansThromboplastinStem Cell NicheProgenitor cellBlood CoagulationEndothelial protein C receptorReview SeriesHematopoietic Stem Cell TransplantationHematopoietic stem cellCell DifferentiationCell BiologyHematologyHematopoietic Stem CellsHematopoiesisCell biologyHaematopoiesis030104 developmental biologymedicine.anatomical_structureStem cellBiomarkersFibrinolytic agentSignal TransductionBlood
researchProduct

Treating severe asthma:Targeting the IL‐5 pathway

2021

Abstract Severe asthma is a heterogeneous disease with different phenotypes based on clinical, functional or inflammatory parameters. In particular, the eosinophilic phenotype is associated with type 2 inflammation and increased levels of interleukin (IL)‐4, IL‐5 and IL‐13). Monoclonal antibodies that target the eosinophilic inflammatory pathways (IL‐5R and IL‐5), namely mepolizumab, reslizumab, and benralizumab, are effective and safe for severe eosinophilic asthma. Eosinophils threshold represents the most indicative biomarker for response to treatment with all three monoclonal antibodies. Improvement in asthma symptoms scores, lung function, the number of exacerbations, history of late‐o…

0301 basic medicineImmunologyReview ArticleDisease03 medical and health scienceschemistry.chemical_compound0302 clinical medicineReslizumabEosinophilicHumansImmunology and AllergyMedicineInvited ReviewsAnti-Asthmatic AgentsInterleukin 5Asthmabusiness.industryAnti-Asthmatic Agents Asthma Eosinophils Interleukin-5medicine.diseaseBenralizumabAsthmaEosinophils030104 developmental biology030228 respiratory systemchemistryImmunologyBiomarker (medicine)Interleukin-5businessMepolizumabmedicine.drug
researchProduct

Primary sjogren syndrome: Focus on innate immune cells and inflammation

2020

Primary Sjogren Syndrome (pSS) is a complex, multifactorial rheumatic disease that mainly targets salivary and lacrimal glands, inducing epithelitis. The cause behind the autoimmunity outbreak in pSS is still elusive; however, it seems related to an aberrant reaction to exogenous triggers such as viruses, combined with individual genetic pre-disposition. For a long time, autoantibodies were considered as the hallmarks of this disease; however, more recently the complex interplay between innate and adaptive immunity as well as the consequent inflammatory process have emerged as the main mechanisms of pSS pathogenesis. The present review will focus on innate cells and on the principal mechani…

0301 basic medicineImmunologyinnate lymphoid cellslcsh:MedicineIFN signatureInflammationDiseaseReviewmedicine.disease_causeAutoimmunityPathogenesis03 medical and health sciences0302 clinical medicinestomatognathic systemDrug DiscoverymedicineInnate lymphoid cellPharmacology (medical)Sjogren syndromeCytokine030203 arthritis & rheumatologyPharmacologyInflammationInnate immunityInnate immune systemSjogren syndrome.business.industryInnate lymphoid celllcsh:RAutoantibodyAcquired immune systemcytokinesstomatognathic diseases030104 developmental biologyInfectious DiseasesImmunologymedicine.symptombusiness
researchProduct

Epigenetic IVD Tests for Personalized Precision Medicine in Cancer

2019

Epigenetic alterations play a key role in the initiation and progression of cancer. Therefore, it is possible to use epigenetic marks as biomarkers for predictive and precision medicine in cancer. Precision medicine is poised to impact clinical practice, patients, and healthcare systems. The objective of this review is to provide an overview of the epigenetic testing landscape in cancer by examining commercially available epigenetic-based in vitro diagnostic tests for colon, breast, cervical, glioblastoma, lung cancers, and for cancers of unknown origin. We compile current commercial epigenetic tests based on epigenetic biomarkers (i.e., DNA methylation, miRNAs, and histones) that can actua…

0301 basic medicineIn Vitro Diagnostic (IVD)lcsh:QH426-470precision medicineReviewBioinformatics03 medical and health sciences0302 clinical medicinemicroRNAGeneticsMedicineEpigeneticscfDNAGenetics (clinical)miRNAEpigenetic biomarkersDNA methylationbiologybusiness.industryCancerepigenetic biomarkerPrecision medicinemedicine.diseaselcsh:Genetics030104 developmental biologyHistone030220 oncology & carcinogenesisDNA methylationcirculating nucleosomesbiology.proteinMolecular MedicinebusinessGlioblastomaFrontiers in Genetics
researchProduct

Molecular Biology of Atherosclerotic Ischemic Strokes

2020

Among the causes of global death and disability, ischemic stroke (also known as cerebral ischemia) plays a pivotal role, by determining the highest number of worldwide mortality, behind cardiomyopathies, affecting 30 million people. The etiopathogenetic burden of a cerebrovascular accident could be brain ischemia (~80%) or intracranial hemorrhage (~20%). The most common site when ischemia occurs is the one is perfused by middle cerebral arteries. Worse prognosis and disablement consequent to brain damage occur in elderly patients or affected by neurological impairment, hypertension, dyslipidemia, and diabetes. Since, in the coming years, estimates predict an exponential increase of people w…

0301 basic medicineInflammasomesCerebral arteriesmicrogliaDiseaseReviewneuroinflammationBrain ischemialcsh:Chemistry0302 clinical medicineatherosclerosiStrokelcsh:QH301-705.5SpectroscopymicroRNAGeneral MedicineMKEYDKK-3Computer Science ApplicationsmicroRNAsBlood-Brain BarrierCardiologymedicine.symptomDectin-1medicine.medical_specialtyIschemiaBrain damageCatalysisInorganic Chemistry03 medical and health sciencesInternal medicineDiabetes mellitusmedicineischemic strokeAnimalsHumansPhysical and Theoretical ChemistryMolecular Biologybusiness.industryOrganic ChemistryAFmedicine.diseaseImmunity InnateNLRP3 inflammasome030104 developmental biologylcsh:Biology (General)lcsh:QD1-999atherosclerosisbusinessBBB030217 neurology & neurosurgeryDyslipidemiaCD200-CD200R
researchProduct

Probiotics Can Cure Oral Aphthous-Like Ulcers in Inflammatory Bowel Disease Patients: A Review of the Literature and a Working Hypothesis

2019

Dysbiosis has been associated with the onset of several chronic autoimmune or inflammatory pathologies (e.g., inflammatory bowel diseases—IBD), because of its primary role in the establishment of a chronic inflammatory process leading to tissue damage. Inflammatory bowel diseases can even involve areas far away from the gut, such as the extraintestinal manifestations involving the oral cavity with the onset of aphthous-like ulcers (ALU). Studies carried out on animal models have shown that intestinal dysbiosis may be related to the development of autoimmune diseases, even if the mechanisms involved are not yet well known. The aim of this paper is to verify the hypothesis that in inflammator…

0301 basic medicineInflammationReviewWorking hypothesisInflammatory bowel diseaseinflammatory bowel diseasesCatalysisInorganic Chemistrylcsh:Chemistry03 medical and health sciences0302 clinical medicineinflammatory bowel diseasemedicinemicrobiotaaphthous-like ulcersAnimalsHumansPhysical and Theoretical ChemistryOral mucosaMolecular BiologyStomatitislcsh:QH301-705.5SpectroscopyNatural coursebusiness.industrydysbiosiOrganic ChemistryInflammatory Bowel DiseasesGeneral Medicinedysbiosismedicine.diseasemuco-microbiotic layerdigestive system diseasesComputer Science ApplicationsGastrointestinal MicrobiomeDisease Models Animalstomatognathic diseases030104 developmental biologymedicine.anatomical_structureprobioticslcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisImmunologyStomatitis Aphthousmedicine.symptombusinessDysbiosisaphthous-like ulcerInternational Journal of Molecular Sciences
researchProduct

Innate immune response to tick-borne pathogens: Cellular and molecular mechanisms induced in the hosts

2020

This article belongs to the Special Issue Inflammasome.

0301 basic medicineInnate immune responseHost Defense MechanismReviewInflammasomelcsh:ChemistryTicksTheileriaTick borne pathogensRickettsialcsh:QH301-705.5SpectroscopyGene ontology analysisgene ontology analysisInflammasomeGeneral MedicineAcquired immune systemComputer Science ApplicationsTick-Borne DiseasesTumor necrosis factor alphamedicine.drugAnaplasma030106 microbiologyEhrlichiaBabesiaBiologyCatalysisMicrobiologyInorganic Chemistry03 medical and health sciencesAntigeninflammasomeparasitic diseasesmedicineAnimalsHumansPhysical and Theoretical ChemistryMolecular BiologyInnate immune systemOrganic Chemistrygene ontology analysibiology.organism_classificationImmunity InnateComplement systemInsect Vectors030104 developmental biologyRickettsialcsh:Biology (General)lcsh:QD1-999innate immune responsetick borne pathogens
researchProduct

Role of subclinical gut inflammation in the pathogenesis of spondyloarthritis

2018

Subclinical gut inflammation occurring in patients affected by spondyloarthritis (SpA) is correlated with the severity of spine inflammation. Several evidences indicate that dysbiosis occurs in SpA, and that may modulate intestinal permeability and intestinal immune responses. The presence of intestinal dysbiosis is accompanied in SpA patients with the presence of zonulin-dependent alterations of gut-epithelial and gut-vascular barriers. The leakage of epithelial and endothelial surface layers is followed by the translocation of bacterial products, such as lipopolysaccharide and intestinal fatty acid binding protein, in the systemic circulation. These bacterial products may downregulate the…

0301 basic medicineInnate immune responseLipopolysaccharideenthesitis-related arthritisCD14Mini ReviewInflammationInflammation mediator03 medical and health scienceschemistry.chemical_compound0302 clinical medicineImmune systemmedicine030203 arthritis & rheumatologyEnthesitis-related arthritilcsh:R5-920Gut microbiomeInnate immune systemIntestinal permeabilitybusiness.industryInnate lymphoid cellGeneral Medicinemedicine.diseaseinflammation mediatorsSettore MED/16 - Reumatologia030104 developmental biologychemistryImmunologyMedicinemedicine.symptombusinesslcsh:Medicine (General)DysbiosisSpondylitis
researchProduct

Considerations for an in vitro, cell-based testing platform for detection of adverse drug-induced inotropic effects in early drug development. Part 1…

2019

Drug-induced effects on cardiac contractility can be assessed through the measurement of the maximal rate of pressure increase in the left ventricle (LVdP/dtmax) in conscious animals, and such studies are often conducted at the late stage of preclinical drug development. Detection of such effects earlier in drug research using simpler, in vitro test systems would be a valuable addition to our strategies for identifying the best possible drug development candidates. Thus, testing platforms with reasonably high throughput, and affordable costs would be helpful for early screening purposes. There may also be utility for testing platforms that provide mechanistic information about how a given d…

0301 basic medicineInotropeDrugIn vitro testComputer sciencemedia_common.quotation_subjectcardiomyocyteReviewCardiomyocyteStem cellsContractilityInotropic statecontractilityContractility03 medical and health sciences0302 clinical medicinestem cellsmyocardiumPharmacology (medical)media_commoninotropic statePharmacologyMyocardiumlcsh:RM1-950Pre-clinical development030104 developmental biologylcsh:Therapeutics. PharmacologyDrug developmentRisk analysis (engineering)030220 oncology & carcinogenesisPressure increaseCell based
researchProduct